Cargando…

Prognostic value of lesion dissemination in doxorubicin, bleomycin, vinblastine, and dacarbazine‐treated, interimPET‐negative classical Hodgkin Lymphoma patients: A radio‐genomic study

We evaluated the prognostic role of the largest distance between two lesions (Dmax), defined by positron emission tomography (PET) in a retrospective cohort of newly diagnosed classical Hodgkin Lymphoma (cHL) patients. We also explored the molecular bases underlying Dmax through a gene expression an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Durmo, Rexhep, Donati, Benedetta, Rebaud, Louis, Cottereau, Anne Segolene, Ruffini, Alessia, Nizzoli, Maria Elena, Ciavarella, Sabino, Vegliante, Maria Carmela, Nioche, Christophe, Meignan, Michel, Merli, Francesco, Versari, Annibale, Ciarrocchi, Alessia, Buvat, Irene, Luminari, Stefano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796042/ https://www.ncbi.nlm.nih.gov/pubmed/35606338 http://dx.doi.org/10.1002/hon.3025

Ejemplares similares

Successful treatment of disseminated interdigitating dendritic cell sarcoma with adriamycin, bleomycin, vinblastine, and dacarbazine chemotherapy
por: Lee, Suk-young, et al.
Publicado: (2012)

Hodgkin lymphoma and female fertility: a multicenter study in women treated with doxorubicin, bleomycin, vinblastine, and dacarbazine
por: Machet, Antoine, et al.
Publicado: (2022)

New Approaches in Characterization of Lesions Dissemination in DLBCL Patients on Baseline PET/CT
por: Cottereau, Anne-Ségolène, et al.
Publicado: (2021)

Dacarbazine/doxorubicin/vinblastine: Lack of efficacy: case report
Publicado: (2022)

Durable Remission in Hodgkin Lymphoma Treated With One Cycle of Bleomycin, Vinblastine, Dacarbazine and Two Doses of Nivolumab and Brentuximab Vedotin
por: Yohannan, Binoy, et al.
Publicado: (2022)

(18)F-FDG PET Maximum-Intensity Projections and Artificial Intelligence: A Win-Win Combination to Easily Measure Prognostic Biomarkers in DLBCL Patients
por: Girum, Kibrom B., et al.
Publicado: (2022)

Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy
por: Lagerlöf, Ingemar, et al.
Publicado: (2022)

Predictive and Prognostic Role of Pre-Therapy and Interim 68Ga-DOTATOC PET/CT Parameters in Metastatic Advanced Neuroendocrine Tumor Patients Treated with PRRT
por: Durmo, Rexhep, et al.
Publicado: (2022)

Deep-Learning (18)F-FDG Uptake Classification Enables Total Metabolic Tumor Volume Estimation in Diffuse Large B-Cell Lymphoma
por: Capobianco, Nicolò, et al.
Publicado: (2021)

Methotrexate-associated Hodgkin Lymphoma in a Patient with Rheumatoid Arthritis Successfully Treated with Brentuximab Vedotin in Combination with Doxorubicin, Vinblastine, and Dacarbazine (BV+AVD)
por: Sekiguchi, Yasunobu, et al.
Publicado: (2020)

The prognostic power of 18F-FDG PET/CT extends to estimating systemic treatment response duration in metastatic castration-resistant prostate cancer (mCRPC) patients
por: Bauckneht, Matteo, et al.
Publicado: (2021)

Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD) plus interferon alpha for metastatic melanoma: a multicentre phase II study.
por: Punt, C. J., et al.
Publicado: (1997)

Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced‐stage, classical Hodgkin lymphoma: A prespecified subgroup analysis of high‐risk patients from the ECHELON‐1 study
por: Hutchings, Martin, et al.
Publicado: (2021)

Dacarbazine Combined Targeted Therapy versus Dacarbazine Alone in Patients with Malignant Melanoma: A Meta-Analysis
por: Jiang, Guan, et al.
Publicado: (2014)

Meta-Analysis of the Safety and Efficacy of Interferon Combined With Dacarbazine Versus Dacarbazine Alone in Cutaneous Malignant Melanoma
por: Xin, Yong, et al.
Publicado: (2016)

Vinblastine in the treatment of Hodgkin's disease.
por: Jelliffe, A. M.
Publicado: (1969)

Inhibition of interferon secretion by vinblastine
por: Havell, EA, et al.
Publicado: (1975)

Vinblastine-induced Acral Hyperpigmentation
por: Chakraborti, Annesha, et al.
Publicado: (2020)

A randomized phase III study comparing dacarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanoma
por: Middleton, M R, et al.
Publicado: (2000)

Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-α in advanced malignant melanoma
por: Daponte, Antonio, et al.
Publicado: (2013)

Q-TWiST analysis comparing ipilimumab/dacarbazine vs placebo/dacarbazine for patients with stage III/IV melanoma
por: Sherrill, B, et al.
Publicado: (2013)

Vinblastine Sulphate in the Treatment of Malignant Disease
por: Bleehen, N. M., et al.
Publicado: (1965)

THE EFFECTS OF VINBLASTINE ON ISOLATED XENOPUS OOCYTES
por: Dumont, James N., et al.
Publicado: (1972)

Modifications on the Basic Skeletons of Vinblastine and Vincristine
por: Keglevich, Péter, et al.
Publicado: (2012)

Vinblastine: Neutropenia and thrombocytopenia: case report
Publicado: (2021)

Diffuse large B-cell lymphoma: the stuff of cell-of-origin and microenvironment
por: Pileri, Stefano A., et al.
Publicado: (2019)

Influence of age on radiomic features in (18)F-FDG PET in normal breast tissue and in breast cancer tumors
por: Boughdad, Sarah, et al.
Publicado: (2018)

Regulation of initial vinblastine influx by P-glycoprotein.
por: Shalinsky, D. R., et al.
Publicado: (1993)

STRUCTURE OF MICROTUBULAR CRYSTALS INDUCED BY VINBLASTINE IN VITRO
por: Marantz, Robert, et al.
Publicado: (1970)

Effect of tau on the vinblastine-induced aggregation of tubulin
Publicado: (1981)

Severe neurotoxicity due to Vinblastine in Hodgkin lymphoma
por: Suresh, Pandalanghat, et al.
Publicado: (2014)

Mechanisms of kinetic stabilization by the drugs paclitaxel and vinblastine
por: Castle, Brian T., et al.
Publicado: (2017)

Treatment of metastatic malignant melanoma with dacarbazine, vindesine and cisplatin.
por: Pectasides, D., et al.
Publicado: (1989)

Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme
por: Fazeny-Dörner, B, et al.
Publicado: (2003)

Dacarbazine mediates antimelanoma effects via NK cells
por: Hervieu, Alice, et al.
Publicado: (2013)

Evaluation of protective effect of amifostine on dacarbazine induced genotoxicity
por: Etebari, M., et al.
Publicado: (2015)

Dacarbazine nanoparticle topical delivery system for the treatment of melanoma
por: Hafeez, Abdul, et al.
Publicado: (2017)

Post first-line dacarbazine or temozolomide in neuroendocrine carcinoma
por: Couronne, Thomas, et al.
Publicado: (2020)

EFFECT OF COLCHICINE AND VINBLASTINE ON THE TOPOGRAPHICAL SEPARATION OF MEMBRANE FUNCTIONS
por: Ukena, Thomas E., et al.
Publicado: (1972)

VINBLASTINE PRODUCES UNIAXIAL, BIREFRINGENT CRYSTALS IN STARFISH OOCYTES
por: Malawista, Stephen E., et al.
Publicado: (1969)

Cannot write session to /tmp/vufind_sessions/sess_np33cer2psah73fnj2pg2bpeul